The IRA requires health plans serving the Part D market to cover all negotiated drugs, and it has been predicted that CMS ...

Private jets owned by six of the largest U.S. drugmakers have touched down in Washington-area airports 127 times this year, ...

Medicare beneficiaries will see major pricing shifts as federal negotiations reshape how costly prescription drugs are paid ...

A new Tufts study found that Medicare price negotiations on biologics with imminent biosimilars could lead to near-term savings, but greater savings are likely from biosimilar competition.

Congress continually struggles to find bipartisan reforms that improve affordability and increase the quality of care; ...

The market for GLP-1 drugs is projected to reach $180 billion in 2034, according to Morningstar Equity Research. Current ...

Pharmaceutical companies agreed to cut Medicare prices for 15 prescription drugs after negotiations led by the Trump ...

Pharmacy leaders say 2026 is shaping up to be a year defined by financial volatility, regulatory pressure and workforce strain — all intensified by upcoming federal drug pricing reforms. Across ...

The Senior Care Pharmacy Coalition (SCPC) unveiled a new ad campaign that calls on Congress to pass the Preserving Patient Access to Long-Term Care Pharmacies Act (HR 5031/S 3159) and highlights the ...

Hospital groups raise issues with 340B rebate pilot program citing cash flow, administrative costs, and unclear rebate denials risks.

A House hearing Wednesday on the topic of how technology can help lower healthcare costs was sidetracked almost immediately ...